Description

7-Ethyl-4,5,6,7,8,9-Hexahydro-2H-3,7-Methanoazacycloundecino[5,4-B]Indol-14B(1H)-Ol 3-Oxide is a complex, polycyclic organic compound with a unique bridged structure. This specialized chemical is valued as a critical advanced intermediate in the synthesis of complex pharmacologically active molecules. It is primarily required by pharmaceutical R&D and fine chemical synthesis teams for developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the research and development of novel active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) or complex alkaloid-based targets.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for discovering new drug candidates.
• Organic Synthesis: Serves as a sophisticated precursor for constructing complex polycyclic and bridged ring systems in academic and industrial laboratories.
• Biochemical Research: Potential use as a tool compound or ligand in biochemical assays and receptor binding studies due to its intricate molecular architecture.
• Fine Chemical Production: Employed in the multi-step synthesis of high-value, low-volume specialty chemicals for advanced applications.

Basic Information

Item	Details
Product Name	7-Ethyl-4,5,6,7,8,9-Hexahydro-2H-3,7-Methanoazacycloundecino[5,4-B]Indol-14B(1H)-Ol 3-Oxide
CAS No.	26066-43-3
Molecular Formula	C20H26N2O2
Molecular Weight	326.44 g/mol
Synonyms	7-Ethyl-4,5,6,7,8,9-hexahydro-2H-3,7-methanoazacycloundecino[5,4-b]indol-14b(1H)-ol 3-oxide; Yohimbine N-oxide derivative; 3α-Hydroxy-16α-carbomethoxy-20α-yohimban-17β-ol N-oxide; 3-Hydroxyyohimbine N-oxide; Corynanthine N-oxide analog; 26066-43-3; (3α,16α,17β,20α)-3-Hydroxy-16-(methoxycarbonyl)-17-methyl-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthren-17-ium-20-carboxylate 1-oxide
EINECS	Contact for details

Quality Control

Our 7-Ethyl-4,5,6,7,8,9-Hexahydro-2H-3,7-Methanoazacycloundecino[5,4-B]Indol-14B(1H)-Ol 3-Oxide is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed specifications are available for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0% Any single impurity ≤ 1.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.